Intestinal transplantation in composite visceral grafts or alone.

PubWeight™: 4.96‹?› | Rank: Top 1%

🔗 View Article (PMC 1242598)

Published in Ann Surg on September 01, 1992

Authors

S Todo1, A G Tzakis, K Abu-Elmagd, J Reyes, K Nakamura, A Casavilla, R Selby, B M Nour, H Wright, J J Fung

Author Affiliations

1: Department of Surgery, University of Pittsburgh School of Medicine, Pennsylvania.

Articles citing this

Cell migration, chimerism, and graft acceptance. Lancet (1992) 12.24

Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology (1993) 8.76

Outcome analysis of 71 clinical intestinal transplantations. Ann Surg (1995) 2.95

Clinical intestinal transplantation: new perspectives and immunologic considerations. J Am Coll Surg (1998) 2.31

Assessment of five-year experience with abdominal organ cluster transplantation. J Am Coll Surg (1995) 2.25

Three years clinical experience with intestinal transplantation. J Am Coll Surg (1994) 2.20

Logistics and technique for combined hepatic-intestinal retrieval. Ann Surg (1992) 1.85

Small intestinal transplantation in humans with or without the colon. Transplantation (1994) 1.74

Immunomodulation for intestinal transplantation by allograft irradiation, adjunct donor bone marrow infusion, or both. Transplantation (2000) 1.53

Clinical intestinal transplantation: a decade of experience at a single center. Ann Surg (2001) 1.44

Intestinal transplantation at the University of Pittsburgh. Transplant Proc (1994) 1.42

Abdominal multivisceral transplantation. Transplantation (1995) 1.37

Small bowel and liver/small bowel transplantation in children. Semin Pediatr Surg (1993) 1.30

Spontaneous and iatrogenically augmented leukocyte chimerism in organ transplant recipients. Transplant Proc (1994) 1.29

Graft-versus-host disease after liver and small bowel transplantation in a child. Clin Transplant (1997) 1.09

Humoral and cellular immunopathology of hepatic and cardiac hamster-into-rat xenograft rejection. Marked stimulation of IgM++bright/IgD+dull splenic B cells. Am J Pathol (1993) 1.06

FK 506 versus cyclosporine. Transplant Proc (1993) 1.03

Lymphoproliferative disease after intestinal transplantation under primary FK 506 immunosuppression. Transplant Proc (1994) 1.03

Amelioration of intestinal dysmotility and stasis by octreotide early after small-bowel autotransplantation in dogs. Am J Surg (1995) 1.03

Intestinal transplantation in children under FK 506 immunosuppression. J Pediatr Surg (1993) 1.02

Epstein Barr virus associated posttransplant lymphoproliferative disease after intestinal transplantation. Transplant Proc (1996) 0.99

Rejection of human intestinal allografts: alone or in combination with the liver. Transplant Proc (1994) 0.99

Themes of liver transplantation. Hepatology (2010) 0.98

History of clinical transplantation. World J Surg (2000) 0.91

Intestinal transplantation in humans under FK 506. Transplant Proc (1993) 0.90

Intestinal transplantation and bacterial overgrowth in humans. Transplant Proc (1994) 0.90

FK506 in solid organ transplantation. Ther Drug Monit (1995) 0.85

Short bowel syndrome. Arch Dis Child (1995) 0.85

Effect of ischemia on the canine large bowel: a comparison with the small intestine. J Surg Res (1996) 0.84

Combined small bowel and reduced auxiliary liver transplantation: case report. World J Gastroenterol (2002) 0.82

The future of small bowel transplantation. Arch Dis Child (1995) 0.81

HLA matching and the point system. Clin Transplant (1993) 0.80

Effect of rejection on electrophysiologic function of canine intestinal grafts: correlation with histopathology and Na-K-ATPase activity. J Invest Surg (1996) 0.79

Current status of intestinal transplantation. Adv Surg (1994) 0.78

The two-way paradigm of transplantation immunology. Clin Immunol Immunopathol (1996) 0.78

Intestinal transplantation. Annu Rev Med (1994) 0.78

Gastrointestinal motility in the immediate postoperative period after intestinal transplantation, with special reference to acute rejection. Transplant Proc (1994) 0.78

Intestinal transplantation: 4-year experience. Transplant Proc (1995) 0.77

Small intestine transplantation today. Langenbecks Arch Surg (2007) 0.77

Clinical intestinal transplantation: experience in Miami. Transplant Proc (1997) 0.77

The birth of clinical organ transplantation. J Am Coll Surg (2001) 0.76

Hepatic transplantation at the University of Pittsburgh: new horizons and paradigms after 30 years of experience. Clin Transpl (1994) 0.76

Improved survival with cytomegalovirus infection after intestinal transplantation in children. Transplant Proc (1996) 0.76

The current status of hepatic transplantation at the University of Pittsburgh. Clin Transpl (1995) 0.76

FK 506 in small bowel transplant recipients: pharmacokinetics and dosing. Transplant Proc (1994) 0.75

The immune response in small bowel transplantation. Ann R Coll Surg Engl (1996) 0.75

MHC class II presenting cells are necessary for the induction of intrathymic tolerance. Ann Surg (1993) 0.75

Chimerism after Whole Organ Transplant. Guthrie J Donald Guthrie Found Med Res (1993) 0.75

Intestinal transplantation at the University of Pittsburgh: six-year experience. Transplant Proc (1997) 0.75

Functional aspects of small bowel transplantation: past, present, and future. Gut (1994) 0.75

Intestinal transplantation in 31 adults. Transplant Proc (1996) 0.75

Is rejection a diffuse or localized process in small-bowel transplantation? Surg Endosc (1994) 0.75

The role of HLA typing in clinical kidney transplants: 30 years later. The blind-folding of HLA matching. Clin Transpl (1993) 0.75

Modifications in combined liver-small bowel transplantation in pigs. World J Gastroenterol (2003) 0.75

Current perspectives of transplantation immunology via the intestine. Transplant Proc (1996) 0.75

The transplantation of gastrointestinal organs. Gastroenterology (1993) 0.75

Blockage of mesenteric lymphatic flow in rats. Pediatr Surg Int (1997) 0.75

Scanning electron microscopic study of cold-stored small bowel: comparison of Euro-Collins and Lactated Ringer's solutions. Dig Dis Sci (2003) 0.75

Articles cited by this

Cell migration, chimerism, and graft acceptance. Lancet (1992) 12.24

The many faces of multivisceral transplantation. Surg Gynecol Obstet (1991) 6.89

Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery (1991) 5.92

Induction of immunological tolerance by porcine liver allografts. Nature (1969) 5.89

Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01

Successful small-bowel/liver transplantation. Lancet (1990) 4.85

Replacement of donor lymphoid tissue in small-bowel transplants. Lancet (1991) 3.85

Transplantation of multiple abdominal viscera. JAMA (1989) 3.59

The physiological response of the small bowel of the dog to ischemia including prolonged in vitro preservation of the bowel with successful replacement and survival. Ann Surg (1959) 3.10

The use of FK-506 for small intestine allotransplantation. Inhibition of acute rejection and prevention of fatal graft-versus-host disease. Transplantation (1990) 2.79

Cadaveric small bowel and small bowel-liver transplantation in humans. Transplantation (1992) 2.75

The Eck fistula in animals and humans. Curr Probl Surg (1983) 2.35

Induction of liver, heart, and multivisceral graft acceptance with a short course of FK 506. Transplant Proc (1990) 2.15

Lymphocyte traffic and graft-versus-host disease after fully allogeneic small bowel transplantation. Transplant Proc (1991) 1.89

Successful orthotopic small bowel transplantation with short-term FK 506 immunosuppressive therapy. Transplant Proc (1990) 1.71

Successful small bowel transplantation in an infant. Transplantation (1992) 1.69

Participation of endothelial cells in the protein C-protein S anticoagulant pathway: the synthesis and release of protein S. J Cell Biol (1986) 1.68

Renal homotransplantation with venous outflow or infusion of antigen into the portal vein of dogs or pigs. Transplantation at portal site. Transplantation (1977) 1.54

Portal versus caval venous drainage of small bowel allografts: technical and metabolic consequences. Surgery (1986) 1.50

Immunologic and metabolic effects of caval versus portal venous drainage in small-bowel transplantation. Surgery (1988) 1.50

The immunology of experimental liver transplantation in the rat. Immunology (1985) 1.45

Successful intestinal transplantation in pigs treated with cyclosporine. Transplantation (1988) 1.36

Successful small bowel allotransplantation in dogs with cyclosporine and prednisone. Transplantation (1984) 1.28

Comparison of the small intestine after multivisceral transplantation with the small intestines transplanted with portal or caval drainage. Transplant Proc (1992) 1.26

Nutritional and metabolic aspects of total small bowel transplantation in inbred rats. Transplant Proc (1987) 1.19

Successful small intestine transplantation. Transplant Proc (1992) 1.17

Intestinal transplantation: current status. Transplant Proc (1989) 1.07

Use of kinetic methods to evaluate D-xylose malabsorption in patients. J Lab Clin Med (1988) 1.04

The effect of bile duct ligation and bile diversion on FK506 pharmacokinetics in dogs. Transplantation (1992) 0.98

Lipiodol absorption and urinary lodide excretion as a screening test for steatorrhea. Clin Chem (1969) 0.93

Comparison of functional activity in host and graft mesenteric lymphoid tissue of rats receiving syngeneic heterotopic small bowel allografts with portal or systemic drainage. Transplant Proc (1992) 0.88

Articles by these authors

Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology (1993) 8.76

The outer membrane proteins of Gram-negative bacteria: biosynthesis, assembly, and functions. Annu Rev Biochem (1978) 7.96

Urban residential environments and senior citizens' longevity in megacity areas: the importance of walkable green spaces. J Epidemiol Community Health (2002) 7.79

The many faces of multivisceral transplantation. Surg Gynecol Obstet (1991) 6.89

T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. Nature (2000) 6.49

Abdominal organ cluster transplantation for the treatment of upper abdominal malignancies. Ann Surg (1989) 5.78

Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) (1988) 5.77

Effects of heating in dodecyl sulfate solution on the conformation and electrophoretic mobility of isolated major outer membrane proteins from Escherichia coli K-12. J Biochem (1976) 5.52

Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01

Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology (1994) 4.32

DNA sequence of the gene for the outer membrane lipoprotein of E. coli: an extremely AT-rich promoter. Cell (1979) 4.31

Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet (1990) 4.18

Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery (1994) 4.16

Liver transplantation in the United States, 1999-2008. Am J Transplant (2010) 3.92

Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine era. Transplantation (1985) 3.91

Replacement of donor lymphoid tissue in small-bowel transplants. Lancet (1991) 3.85

Elucidation of the Erwinia uredovora carotenoid biosynthetic pathway by functional analysis of gene products expressed in Escherichia coli. J Bacteriol (1990) 3.78

The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans. J Biol Chem (1994) 3.75

Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice. Genes Cells (1999) 3.69

Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology (1983) 3.67

Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation (1995) 3.63

Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg (1991) 3.57

Canine kidney transplantation with FK-506 alone or in combination with cyclosporine and steroids. Transplant Proc (1987) 3.55

Role of positive charge on the amino-terminal region of the signal peptide in protein secretion across the membrane. Proc Natl Acad Sci U S A (1982) 3.44

Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin. J Exp Med (1992) 3.42

Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics. Transplant Proc (1991) 3.40

Cardiovascular anomaly, impaired actin bundling and resistance to Src-induced transformation in mice lacking p130Cas. Nat Genet (1998) 3.38

Parallel neural networks for learning sequential procedures. Trends Neurosci (1999) 3.35

Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology (1991) 3.34

Early trials with FK 506 as primary treatment in liver transplantation. Transplant Proc (1990) 3.29

Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron (1987) 3.26

Rejection of multivisceral allografts in rats: a sequential analysis with comparison to isolated orthotopic small-bowel and liver grafts. Surgery (1990) 3.18

Redox regulation of cellular activation. Annu Rev Immunol (1997) 3.17

Calreticulin: one protein, one gene, many functions. Biochem J (1999) 3.16

The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver. Transplantation (1991) 3.14

Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation. Lancet (1997) 3.11

Natural history of branch duct intraductal papillary-mucinous neoplasms of the pancreas without mural nodules: long-term follow-up results. Gut (2007) 3.11

Orthotopic liver transplantation in dogs receiving FK-506. Transplant Proc (1987) 3.11

Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese. Mol Pharmacol (1994) 3.05

Outcome analysis of 71 clinical intestinal transplantations. Ann Surg (1995) 2.95

Different sensitivity to wortmannin of two vacuolar sorting signals indicates the presence of distinct sorting machineries in tobacco cells. J Cell Biol (1995) 2.93

Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg (2000) 2.91

Calreticulin is essential for cardiac development. J Cell Biol (1999) 2.88

Experience in 1,000 liver transplants under cyclosporine-steroid therapy: a survival report. Transplant Proc (1988) 2.87

Functional characterization of infiltrating T lymphocytes in human hepatic allografts. Hum Immunol (1986) 2.84

Hematolymphoid cell trafficking, microchimerism, and GVH reactions after liver, bone marrow, and heart transplantation. Transplant Proc (1993) 2.81

Synergistic release of Ca2+ from IP3-sensitive stores evoked by synaptic activation of mGluRs paired with backpropagating action potentials. Neuron (1999) 2.79

Metastatic patterns of prostatic cancer. Correlation between sites and number of organs involved. Cancer (1984) 2.78

Experimental investigation of geologically produced antineutrinos with KamLAND. Nature (2005) 2.75

Cadaveric small bowel and small bowel-liver transplantation in humans. Transplantation (1992) 2.75

Loss of teratogenic response to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking the Ah (dioxin) receptor. Genes Cells (1997) 2.72

Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populations. Clin Pharmacol Ther (1985) 2.69

Construction of versatile expression cloning vehicles using the lipoprotein gene of Escherichia coli. EMBO J (1982) 2.68

The association of Epstein-Barr virus with smooth-muscle tumors occurring after organ transplantation. N Engl J Med (1995) 2.68

Distribution of the insertion sequence IS1 in gram-negative bacteria. Nature (1981) 2.63

Management of intestinal transplantation in humans. Transplant Proc (1992) 2.62

Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction. Circ Res (2001) 2.62

Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. Arthritis Rheum (2000) 2.61

Rac1 is required for the formation of three germ layers during gastrulation. Oncogene (1998) 2.61

Effect of hepatic dysfunction and T tube clamping on FK 506 pharmacokinetics and trough concentrations. Transplant Proc (1990) 2.60

Suppression of allograft rejection with FK506. I. Prolonged cardiac and liver survival in rats following short-course therapy. Transplantation (1990) 2.59

Incidence and treatment of rejection episodes in primary orthotopic liver transplantation under FK 506. Transplant Proc (1991) 2.59

Cardiac fibrosis in mice lacking brain natriuretic peptide. Proc Natl Acad Sci U S A (2000) 2.58

The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: a pilot study. Hepatology (1997) 2.57

K-ras is essential for the development of the mouse embryo. Oncogene (1997) 2.57

Messenger ribonucleic acid of the lipoprotein of the Escherichia coli outer membrane. II. The complete nucleotide sequence. J Biol Chem (1980) 2.57

FK506 "rescue" for resistant rejection of renal allografts under primary cyclosporine immunosuppression. Transplantation (1994) 2.50

Pregnancy after liver transplantation under tacrolimus. Transplantation (1997) 2.50

A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine. Transplant Proc (1991) 2.49

Pharmacokinetics of FK 506: preclinical and clinical studies. Transplant Proc (1990) 2.48

Propeptide of a precursor to a plant vacuolar protein required for vacuolar targeting. Proc Natl Acad Sci U S A (1991) 2.48

Carcinoma of the stomach in incipient phase: its histogenesis and histological appearances. Gan (1968) 2.44

Regulatory region of the gene for the ompA protein, a major outer membrane protein of Escherichia coli. Proc Natl Acad Sci U S A (1980) 2.44

Murine homolog of SALL1 is essential for ureteric bud invasion in kidney development. Development (2001) 2.42

Prioritization and organ distribution for liver transplantation. JAMA (1994) 2.38

Osteoarthritis development in novel experimental mouse models induced by knee joint instability. Osteoarthritis Cartilage (2005) 2.36

Fluorescence in situ hybridization using 16S rRNA-targeted oligonucleotides reveals localization of methanogens and selected uncultured bacteria in mesophilic and thermophilic sludge granules. Appl Environ Microbiol (1999) 2.33

The human amygdala plays an important role in gaze monitoring. A PET study. Brain (1999) 2.33

The antibody crossmatch in liver transplantation. Surgery (1986) 2.33

The incidence, timing, and management of biliary tract complications after orthotopic liver transplantation. Ann Surg (1994) 2.32

Clinical intestinal transplantation: new perspectives and immunologic considerations. J Am Coll Surg (1998) 2.31